7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, YJ; Kim, WB; Kwon, JW; Lee, HJ; Lee, MG; Yang, J | 1 |
1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluoro-alpha-talopyranosyl)adriamycinone- 14-beta-alaniate hydrochloride and Alloxan Diabetes
Article | Year |
---|---|
Pharmacokinetic changes of M1, M2, M3, and M4 after intravenous administration of a new anthracycline, DA-125, to alloxan-induced diabetes mellitus rats.
Topics: Alloxan; Animals; Antibiotics, Antineoplastic; Area Under Curve; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Doxorubicin; Half-Life; Kidney; Liver; Organ Size; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1996 |